Theodore J. Criares

Array ( [id] => 3648338 [patent_doc_number] => 05629315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Treatment of diseases using enantiomerically pure hydroxylated xanthine compounds' [patent_app_type] => 1 [patent_app_number] => 8/456900 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16538 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629315.pdf [firstpage_image] =>[orig_patent_app_number] => 456900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590607 [patent_doc_number] => 05567704 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => 'R-enatiomerically pure hydroxylated xanthine compounds to treat baldness' [patent_app_type] => 1 [patent_app_number] => 8/457683 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16609 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567704.pdf [firstpage_image] =>[orig_patent_app_number] => 457683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3582506 [patent_doc_number] => 05580874 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Enatiomerically pure hydroxylated xanthine compounds' [patent_app_type] => 1 [patent_app_number] => 8/457685 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16580 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580874.pdf [firstpage_image] =>[orig_patent_app_number] => 457685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657632 [patent_doc_number] => 05622975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Methods for inhibiting vascular smooth muscle cell migration' [patent_app_type] => 1 [patent_app_number] => 8/457700 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3397 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622975.pdf [firstpage_image] =>[orig_patent_app_number] => 457700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624387 [patent_doc_number] => 05612349 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms' [patent_app_type] => 1 [patent_app_number] => 8/457062 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16593 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612349.pdf [firstpage_image] =>[orig_patent_app_number] => 457062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626019 [patent_doc_number] => 05620984 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases' [patent_app_type] => 1 [patent_app_number] => 8/456898 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16532 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620984.pdf [firstpage_image] =>[orig_patent_app_number] => 456898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3582491 [patent_doc_number] => 05580873 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Enatiomerically pure hydroxylated xanthine compounds to treat proliferative vascular diseases' [patent_app_type] => 1 [patent_app_number] => 8/456899 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16581 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580873.pdf [firstpage_image] =>[orig_patent_app_number] => 456899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4052675 [patent_doc_number] => 05932602 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Treatment of platelet derived growth factor related disorders such as cancers' [patent_app_type] => 1 [patent_app_number] => 8/456735 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 5 [patent_no_of_words] => 39146 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932602.pdf [firstpage_image] =>[orig_patent_app_number] => 456735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726999 [patent_doc_number] => 05700822 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Treatment of platelet derived growth factor related disorders such as cancers' [patent_app_type] => 1 [patent_app_number] => 8/457047 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 39143 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700822.pdf [firstpage_image] =>[orig_patent_app_number] => 457047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3599273 [patent_doc_number] => 05559136 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Treatment of Alzheimer\'s disease using azacyclic compounds' [patent_app_type] => 1 [patent_app_number] => 8/455300 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8133 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559136.pdf [firstpage_image] =>[orig_patent_app_number] => 455300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586985 [patent_doc_number] => 05552395 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => '.DELTA.9(11)-dehydro-8-isoestrone used to treat alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/450960 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6043 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552395.pdf [firstpage_image] =>[orig_patent_app_number] => 450960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3506984 [patent_doc_number] => 05569676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-29 [patent_title] => 'Method for the treatment of osteoarthritis' [patent_app_type] => 1 [patent_app_number] => 8/449066 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1137 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/569/05569676.pdf [firstpage_image] =>[orig_patent_app_number] => 449066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3547614 [patent_doc_number] => 05545635 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Inhibiting bone loss with equilenin' [patent_app_type] => 1 [patent_app_number] => 8/448061 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3224 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545635.pdf [firstpage_image] =>[orig_patent_app_number] => 448061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689620 [patent_doc_number] => 05691375 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/448211 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6694 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691375.pdf [firstpage_image] =>[orig_patent_app_number] => 448211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661670 [patent_doc_number] => 05648380 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Anti-inflammatory wound healing compositions and methods for preparing and using same' [patent_app_type] => 1 [patent_app_number] => 8/445845 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 28463 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648380.pdf [firstpage_image] =>[orig_patent_app_number] => 445845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4058692 [patent_doc_number] => 05863938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Antibacterial-wound healing compositions and methods for preparing and using same' [patent_app_type] => 1 [patent_app_number] => 8/446963 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 27810 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863938.pdf [firstpage_image] =>[orig_patent_app_number] => 446963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3703289 [patent_doc_number] => 05674912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Sunscreen-wound healing compositions and methods for preparing and using same' [patent_app_type] => 1 [patent_app_number] => 8/446979 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 31917 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674912.pdf [firstpage_image] =>[orig_patent_app_number] => 446979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729723 [patent_doc_number] => 05652274 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Therapeutic-wound healing compositions and methods for preparing and using same' [patent_app_type] => 1 [patent_app_number] => 8/445813 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 77 [patent_figures_cnt] => 90 [patent_no_of_words] => 82813 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652274.pdf [firstpage_image] =>[orig_patent_app_number] => 445813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658670 [patent_doc_number] => 05658957 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Immunostimulating wound healing compositions and method for preparing and using same' [patent_app_type] => 1 [patent_app_number] => 8/446986 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 29975 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658957.pdf [firstpage_image] =>[orig_patent_app_number] => 446986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3843455 [patent_doc_number] => 05708035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Methods of use and compositions of R(-) fluoxetine' [patent_app_type] => 1 [patent_app_number] => 8/446348 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7788 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/708/05708035.pdf [firstpage_image] =>[orig_patent_app_number] => 446348 [rel_patent_id] =>[rel_patent_doc_number] =>)